首页> 外文期刊>Nature >Direct conversion of human fibroblasts to multilineage blood progenitors
【24h】

Direct conversion of human fibroblasts to multilineage blood progenitors

机译:人类成纤维细胞直接转化为多谱系血液祖细胞

获取原文
获取原文并翻译 | 示例
       

摘要

As is the case for embryo-derived stem cells, application of reprogrammed human induced pluripotent stem cells is limited by our understanding of lineage specification. Here we demonstrate the ability to generate progenitors and mature cells of the haematopoietic fate directly from human dermal fibroblasts without establishing pluripotency. Ectopic expression of OCT4 (also called POU5F1)-activated haematopoietic transcription factors, together with specific cytokine treatment, allowed generation of cells expressing the pan-leukocyte marker CD45. These unique fibroblast-derived cells gave rise to granulocytic, monocytic, megakaryocytic and erythroid lineages, and demonstrated in vivo engraftment capacity. We note that adult haematopoietic programs are activated, consistent with bypassing the pluripotent state to generate blood fate: this is distinct from haematopoiesis involving pluripotent stem cells, where embryonic programs are activated. These findings demonstrate restoration of multipotency from human fibroblasts, and suggest an alternative approach to cellular reprogramming for autologous cell-replacement therapies that avoids complications associated with the use of human pluripotent stem cells.
机译:与胚胎干细胞一样,重编程的人诱导多能干细胞的应用受到我们对谱系规范的理解的限制。在这里,我们证明了直接从人真皮成纤维细胞产生造血命运的祖细胞和成熟细胞的能力,而没有建立多能性。 OCT4(也称为POU5F1)激活的造血转录因子的异位表达,再加上特定的细胞因子处理,可产生表达泛白细胞标记CD45的细胞。这些独特的成纤维细胞衍生细胞产生了粒细胞,单核细胞,巨核细胞和红系谱系,并证明了其在体内的移植能力。我们注意到,成人造血程序被激活,与绕过多能状态产生血液命运相一致:这与涉及多能干细胞的造血作用不同,后者的胚胎程序被激活。这些发现证明了从人成纤维细胞中恢复多能性,并提出了用于自体细胞置换疗法的细胞重编程的替代方法,其避免了与使用人多能干细胞相关的并发症。

著录项

  • 来源
    《Nature》 |2010年第7323期|p.521-526|共6页
  • 作者单位

    Stem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada L8N 3Z5;

    rnStem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada L8N 3Z5;

    rnStem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada L8N 3Z5;

    rnStem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada L8N 3Z5 Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8N 3Z5;

    rnStem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada L8N 3Z5 Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8N 3Z5;

    rnStem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada L8N 3Z5;

    rnStem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada L8N 3Z5;

    rnStem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada L8N 3Z5 Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8N 3Z5;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:55:21

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号